This Tech-Focused ARK Invest ETF Is Up Around 36% This Year. Is It Still a Good Buy?

The ARK Autonomous Technology & Robotics ETF (ARKQ) — a $1.8 billion fund with a 0.75% expense ratio and roughly 30–50 holdings — has returned 36% YTD through Nov. 17, 2025 versus the S&P 500’s 13%, driven largely by outsized gains in Kratos (+166%), Palantir (+126%) and AMD (+99%). Top-five weights are Tesla 12.2%, Teradyne 9.4%, Kratos 7.3%, Palantir 6.2% and AMD 5.2%; North American stocks comprise 91% and median market cap is ~$38 billion. Despite strong recent performance and thematic exposure to AI, automation and defense, the ETF is concentrated, carries above-average fees and is vulnerable to a tech sell-off (it fell 47% in 2022), so the author recommends a cautious, wait-and-see approach unless investors can tolerate significant volatility and multi-year holding periods.

Analysis

Market structure: The winners are high-performance compute and AI software suppliers (AMD, PLTR) and niche defense contractors (KTOS) that capture scarce compute capacity and classified contracts; losers are legacy CPU vendors, non-AI auto suppliers and broad-cap weighted passive funds that dilute concentrated alpha. Pricing power is shifting toward fabs and software providers with ~6–18 month lead times for capacity, implying 10–30% pricing premia for HBM/GPU-class silicon until new capacity ramps. Cross-asset effects: equity flows into these names raise equity volatility and skew, put modest upward pressure on real yields if capex expectations rise, support copper/palladium and weigh on USD if risk-on persists.

Risk assessment: Tail risks include AI regulatory clampdowns, US-China export controls, a semiconductor cyclical downturn and defense budget reprioritization — any could inflict 30–60% drawdowns on small-cap winners. Immediate (days) risk is momentum reversal; short-term (3–12 months) risk centers on earnings/guidance and capacity ramp timing; long-term (2–5 years) supports secular AI adoption but with large cyclical troughs. Hidden dependencies: ARKQ’s concentration (top 5 ~40%+) and retail/ETF flows amplify gamma squeezes; catalysts to watch are large defense awards, AMD wafer utilization reports and top-3 customers’ AI deployments.

Trade implications: Tactical direct longs: size exposures modestly and prefer defined-risk options — e.g., 6–9 month call spreads on AMD/PLTR and selective small-cap KTOS equity with strict stops. Relative trades: long AMD vs short INTC to capture secular share shift; use buy-write or call spreads on ARKQ after >15% rallies to harvest premium. Sector rotation: trim broad tech by 3–5% and deploy into industrials/defense ETFs or specific mid-cap suppliers; enter on 10–20% pullbacks or post-earnings confirmation.

Contrarian angles: Consensus underestimates how quickly capex can erode pricing power — a 12–18 month capacity add could turn current 20–30% premiums into overcapacity and 30–50% de-rating for smaller suppliers. The recent re-rating may be overdone in names with concentrated customer risk; historically (2016–18, 2020–22) similar thematic rallies saw rapid reversals, so size and use of spreads are critical to avoid permanent capital loss.

Key Decisions for Investors

• Establish a 2–3% portfolio position in AMD (AMD) using a defined-risk 9-month call spread: buy a call ~20% OTM and sell a call ~45% OTM, target IRR if AMD appreciates >30%, max loss = premium paid; add to position only if wafer utilization >85% for two consecutive months.
• Initiate a 1–2% position in Palantir (PLTR) via stock or 6–9 month 25% OTM call purchase, scale to 3% only after two consecutive quarters of revenue beat and positive cash-flow guidance; set a stop-loss at -25% from entry.
• Execute a relative value pair: long AMD (1.5% notional) vs short Intel (INTC) (1.0% notional) to capture secular compute share shift; trim/close if spread widens or narrows by >15% or after 3 quarters.
• Reduce passive broad-tech ETF exposure by 3–5% and redeploy into defense/industrial exposure: buy ITA or IYT equal-weighted to 3–5% or add KTOS 0.5–1% small-cap long with a 20% stop and a 12-month take-profit objective of +50%; monitor defense contract announcements and US DoD budget allocations over the next 30–90 days and only increase defense exposure after at least one multi-year contract award is confirmed.